Susquehanna International Group’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,845
| Closed | -$28.1K | – | 6140 |
|
|
2024
Q3 | $28.1K | Buy |
+1,845
| New | +$28.1K | ﹤0.01% | 5367 |
|
|
2023
Q2 | – | Sell |
-27
| Closed | -$15.4K | – | 5617 |
|
|
2023
Q1 | $15.4K | Buy |
27
+1
| +4% | +$571 | ﹤0.01% | 5659 |
|
|
2022
Q4 | $20.1K | Buy |
+26
| New | +$20.1K | ﹤0.01% | 5368 |
|
|
2022
Q3 | – | Sell |
-62
| Closed | -$73K | – | 6089 |
|
|
2022
Q2 | $73K | Buy |
62
+19
| +44% | +$22.4K | ﹤0.01% | 5128 |
|
|
2022
Q1 | $71K | Sell |
43
-106
| -71% | -$175K | ﹤0.01% | 5227 |
|
|
2021
Q4 | $383K | Buy |
149
+81
| +119% | +$208K | ﹤0.01% | 4171 |
|
|
2021
Q3 | $284K | Buy |
68
+26
| +62% | +$109K | ﹤0.01% | 4351 |
|
|
2021
Q2 | $498K | Buy |
+42
| New | +$498K | ﹤0.01% | 3901 |
|